Tuesday, June 5, 2012
BMS...anti-PD1
Hear Ye! Hear Ye! While, of course, we are all enthralled with the excellent (under the sucky ass circumstances) reports the BMS anti-PD1 product (formerly MDX 1106) is garnering at ASCO....here's the latest news from the business pages....Bristol Myers Squibb expects to make 4 BILLION dollars on their anti-PD1 product in its first year after approval. You're welcome, BMS. It's been a real dealie-o to be your lab rat. The only worse fate are all the folks who didn't get the privilege now or when you start charging the big bucks!!!!! FOUR BILLION DOLLARS OFF THE BACKS OF DESPERATE PEOPLE - Wow! - c
Subscribe to:
Post Comments (Atom)
Oh my God, how many people does that represent? That's horrible!
ReplyDeleteI'm not sure what you mean. I have no numbers for the people who did not make the trials that I am truly lucky enough to be in...but if you check the MIF or MPIP forums, there are huge numbers of people wishing they could gain access to these trials. And the majority of people with melanoma are NOT posting there or here!!! Then....should this drug go to phase III trials at the end of the year...as is hoped...and the results hold...it is unclear when...though probably a couple of years, before the FDA approves it for the general public...and then....no telling what BMS will charge for it...but clearly enough for them to clear a bundle. Our great free market economy at work!!!!
ReplyDeleteI wish I knew how much the product is actually costing BMS to produce. I don't see how the pharmaceutical company deal makers look themselves in the mirror.
ReplyDeleteYeah....stinky canned corn smelling stuff! If I only thought it really smelled as nice as niblets!!! If BMS wants good PR they are going to have to work on that!!!!
ReplyDeleteI just wondered how many people 4 billion worth would treat...
ReplyDeleteAnd this is why health care needs to be reformed. You are so lucky, but it makes me so very angry that there is a price like this on health!
ReplyDelete